Elevance Health Inc. (ELV)
NYSE: ELV
· Real-Time Price · USD
360.15
-35.61 (-9.00%)
At close: Jul 02, 2025, 10:37 AM
-9.00% (1D)
| Bid | 359.74 |
| Market Cap | 81.37B |
| Revenue (ttm) | 183.12B |
| Net Income (ttm) | 5.92B |
| EPS (ttm) | 25.69 |
| PE Ratio (ttm) | 14.02 |
| Forward PE | 9.94 |
| Analyst | Buy |
| Ask | 360.49 |
| Volume | 1,342,388 |
| Avg. Volume (20D) | 1,805,011 |
| Open | 367.20 |
| Previous Close | 395.76 |
| Day's Range | 358.03 - 374.19 |
| 52-Week Range | 357.45 - 567.26 |
| Beta | 0.62 |
Analyst Forecast
According to 0 analyst ratings, the average rating for ELV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Elevance Health Inc. is scheduled to release its earnings on Jul 16, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 hours ago
Shares of health insurance stocks are trading lowe...
Unlock content with
Pro Subscription
1 month ago
-3.9%
Shares of health insurance stocks are trading lower after CMS announced a strategy to enhance and accelerate Medicare Advantage audits.
